Joseph Shulman

Chief Tech/Sci/R&D Officer at RHYTHM PHARMACEUTICALS, INC.

Net worth: 1 145 $ as of 2024-04-29

49 year

Health Technology

Consumer Services

Joseph Shulman active positions

Companies	Position	Start	End
RHYTHM PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	2020-07-26	-

Companies	Position	Start	End
RA PHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	2019-06-30	2020-06-30
NOVELION THERAPEUTICS INC.	Chief Tech/Sci/R&D Officer	2014-08-31	2019-06-30

Boston University	Masters Business Admin
University of Miami	Undergraduate Degree

International

United States	5
Canada	2

Operational

Sectoral

Health Technology	4
Consumer Services	3

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
RHYTHM PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Ra Pharmaceuticals, Inc. Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA.	Health Technology
Novelion Therapeutics, Inc. Novelion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Novelion Therapeutics, Inc. engaged in the development and commercialization of pharmaceuitical products. It focused in providing new standards of care for individuals living with rare diseases. The company was founded on February 3, 1981 and was headquartered in Vancouver, Canada.	Health Technology

Private companies

Health Technology